EXHIBIT 10.28 FIRST AMENDMENT TO LEASE THE FIRST AMENDMENT TO LEASE (this "FIRST AMENDMENT") is made as of the 17th day of November, 1998, by and between BIOLEASE, INC., a Massachusetts corporation ("Landlord") and BIOTRANSPLANT INCORPORATED, a...Lease • March 29th, 2000 • Biotransplant Inc • Pharmaceutical preparations
Contract Type FiledMarch 29th, 2000 Company Industry
Exhibit 10.7 SHAREHOLDERS AGREEMENT Date: 5 April 1994Shareholder Agreement • March 12th, 2001 • Biotransplant Inc • Pharmaceutical preparations • Victoria
Contract Type FiledMarch 12th, 2001 Company Industry Jurisdiction
BIOTRANSPLANT INC. ("BTI")Shareholders' Agreement • March 12th, 2001 • Biotransplant Inc • Pharmaceutical preparations
Contract Type FiledMarch 12th, 2001 Company Industry
WITNESSETH:Supply Agreement • November 14th, 1996 • Biotransplant Inc • Pharmaceutical preparations • Massachusetts
Contract Type FiledNovember 14th, 1996 Company Industry Jurisdiction
BY-LAWSBy-Laws • December 10th, 2001 • Biotransplant Inc • Pharmaceutical preparations
Contract Type FiledDecember 10th, 2001 Company Industry
AMONGShareholder Agreement • November 13th, 2000 • Biotransplant Inc • Pharmaceutical preparations
Contract Type FiledNovember 13th, 2000 Company Industry
AGREEMENTConfidentiality Agreement • May 15th, 2001 • Biotransplant Inc • Pharmaceutical preparations • Massachusetts
Contract Type FiledMay 15th, 2001 Company Industry Jurisdiction
SECTION 1. DEFINITIONSCollaboration and License Agreement • November 12th, 1997 • Biotransplant Inc • Pharmaceutical preparations • New York
Contract Type FiledNovember 12th, 1997 Company Industry Jurisdiction
Exhibit No. 10.6 Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. EXTENSION OF RESEARCH AND LICENSE AGREEMENT BETWEEN THE GENERAL HOSPITAL CORPORATION AND BIOTRANSPLANT...Research and License Agreement • March 12th, 2001 • Biotransplant Inc • Pharmaceutical preparations
Contract Type FiledMarch 12th, 2001 Company Industry
WITNESSETH:License Agreement • April 10th, 2001 • Biotransplant Inc • Pharmaceutical preparations • Maryland
Contract Type FiledApril 10th, 2001 Company Industry Jurisdiction
August 19, 2002Employment Agreement • November 19th, 2002 • Biotransplant Inc • Pharmaceutical preparations • Massachusetts
Contract Type FiledNovember 19th, 2002 Company Industry Jurisdiction
1 EXHIBIT 10.1 CONFIDENTIAL MATERIAL OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE OMISSIONS. DEVELOPMENT AND SUPPLY AGREEMENT THIS DEVELOPMENT AND SUPPLY AGREEMENT, including the attached Exhibits (the...Development and Supply Agreement • November 14th, 1996 • Biotransplant Inc • Pharmaceutical preparations • California
Contract Type FiledNovember 14th, 1996 Company Industry Jurisdiction
August 10, 1999 Fleet National Bank One Federal Street Boston, MA 02110 Gentlemen: This letter agreement will set forth certain understandings between BioTransplant Incorporated, a Delaware corporation (the "Borrower") and Fleet National Bank (the...Term Loan Agreement • November 15th, 1999 • Biotransplant Inc • Pharmaceutical preparations • Massachusetts
Contract Type FiledNovember 15th, 1999 Company Industry Jurisdiction
FIRST AMENDMENT TO MASTER LOAN AND SECURITY AGREEMENTMaster Loan and Security Agreement • August 14th, 2001 • Biotransplant Inc • Pharmaceutical preparations • Illinois
Contract Type FiledAugust 14th, 2001 Company Industry JurisdictionTHIS FIRST AMENDMENT TO MASTER LOAN AND SECURITY AGREEMENT (the “Amendment”), dated as of May 15, 2001, by and between Eligix, Inc. (the “Borrower” or “Eligix”), a Delaware corporation, having its principal place of business and chief executive office at 200 Boston Avenue, Medford, Massachusetts, 02139, and TRANSAMERICA BUSINESS CREDIT CORPORATION (the “Lender”), a Delaware corporation, having its principal office at Riverway II, West Office Tower, 9399 West Higgins Road, Rosemont, Illinois, 60018.
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. AGREEMENTConfidentiality Agreement • August 14th, 2001 • Biotransplant Inc • Pharmaceutical preparations • California
Contract Type FiledAugust 14th, 2001 Company Industry JurisdictionTHIS AGREEMENT is made effective as of the 2nd day of June, 2000, (the “Effective Date”) by and between COULTER PHARMACEUTICAL, INC., a Delaware corporation, located at 600 Gateway Boulevard, South San Francisco, CA 94080 (“Coulter”), and Eligix, Inc., located at 200 Boston Avenue, Medford, MA 02155 (“Eligix”).
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. MINI-SWINE TRANSFER AND MAINTENANCE AGREEMENT THIS MINI-SWINE TRANSFER AND MAINTENANCE AGREEMENT (the "Agreement") is made as...Mini-Swine Transfer and Maintenance Agreement • August 14th, 1998 • Biotransplant Inc • Pharmaceutical preparations • Massachusetts
Contract Type FiledAugust 14th, 1998 Company Industry Jurisdiction
MASTER LOAN AND SECURITY AGREEMENTMaster Loan and Security Agreement • August 14th, 2001 • Biotransplant Inc • Pharmaceutical preparations • Illinois
Contract Type FiledAugust 14th, 2001 Company Industry JurisdictionTHIS AGREEMENT dated as of July 28, 1999, is made by Eligix, Inc. (the "Borrower"), a Delaware corporation having its principal place of business and chief executive office at 200 Boston Avenue, Medford, Massachusetts, 02139 in favor of Transamerica Business Credit Corporation, a Delaware corporation (the "Lender"), having its principal office at Riverway II, West Office Tower, 9399 West Higgins Road, Rosemont, Illinois 60018.
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. LICENSE, ASSIGNMENT AND SUPPLY AGREEMENTLicense, Assignment and Supply Agreement • August 14th, 2001 • Biotransplant Inc • Pharmaceutical preparations • Delaware
Contract Type FiledAugust 14th, 2001 Company Industry JurisdictionTHIS LICENSE, ASSIGNMENT AND SUPPLY AGREEMENT (the "Agreement”) is effective as of February 13, 1997 (the "Effective Date"), by and between COULTER CORPORATION (hereinafter "Coulter Corporation") and its wholly-owned subsidiary COULTER INTERNATIONAL CORPORATION (hereinafter "CIC"), each having its respective principal place of business at 11800 S.W. 147th Avenue, Miami, Florida 33196, and COULTER CELLULAR THERAPIES, INC. (hereinafter "CCTI"), having its principal place of business at 3000 Sand Hill Road, Building 3, Suite 255, Menlo Park, California 94025. Coulter Corporation and its Affiliates (including, but not limited to, CIC) shall be referred to collectively in this Agreement as "Coulter".
BETWEEN BIOTRANSPLANT INC. ("BTI")Agreement to Further Vary Shareholders' Agreement • March 12th, 2001 • Biotransplant Inc • Pharmaceutical preparations
Contract Type FiledMarch 12th, 2001 Company Industry
CUMMINGS PROPERTIES MANAGEMENT, INC. STANDARD FORM COMMERCIAL LEASECommercial Lease • August 14th, 2001 • Biotransplant Inc • Pharmaceutical preparations • Massachusetts
Contract Type FiledAugust 14th, 2001 Company Industry JurisdictionIn consideration of the covenants herein contained, Cummings Properties Management, Inc., hereinafter called LESSOR, does hereby lease to Coulter Cellular Therapies, Inc. (a Massachusetts corporation), 20 Hampden Street, Roxbury, Massachusetts 02119 hereinafter called LESSEE, the following described premises, hereinafter called the leased premises: approximately 33,048 square feet (including 10.65% common area) at 200 Boston Avenue, Suites 2100, 2400, 2600, 2900 and 1475, Medford, Massachusetts 02155.